Literature DB >> 10867702

On the oxygenation-dependent (129)Xe T (1) in blood.

J Wolber1, A Cherubini, M O Leach, A Bifone.   

Abstract

The spin-lattice relaxation time, T(1), of hyperpolarized (129)Xe in blood is sensitive to blood oxygenation. In particular, it has been shown that (129)Xe T(1) is shorter in venous blood than in arterial blood. We have studied the T(1) of hyperpolarized (129)Xe dissolved in human blood as a function of blood oxygenation level, sO(2), in the physiological oxygenation range. We show that the (129)Xe relaxation rate, T(1)(-1), varies in a nonlinear fashion as a function of sO(2). This finding suggests that direct interaction of xenon with the paramagnetic heme group of deoxyhemoglobin is not the dominant oxygenation-dependent relaxation mechanism for (129)Xe in blood. These results corroborate the idea that the oxygenation-dependence of (129)Xe T(1) is determined by conformational changes of hemoglobin induced by oxygen binding. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867702     DOI: 10.1002/1099-1492(200006)13:4<234::aid-nbm632>3.0.co;2-k

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  3 in total

Review 1.  Hyperpolarized and inert gas MRI: the future.

Authors:  Marcus J Couch; Barbara Blasiak; Boguslaw Tomanek; Alexei V Ouriadov; Matthew S Fox; Krista M Dowhos; Mitchell S Albert
Journal:  Mol Imaging Biol       Date:  2015-04       Impact factor: 3.488

2.  Continuously infusing hyperpolarized 129Xe into flowing aqueous solutions using hydrophobic gas exchange membranes.

Authors:  Zackary I Cleveland; Harald E Möller; Laurence W Hedlund; Bastiaan Driehuys
Journal:  J Phys Chem B       Date:  2009-09-17       Impact factor: 2.991

Review 3.  In vivo methods and applications of xenon-129 magnetic resonance.

Authors:  Helen Marshall; Neil J Stewart; Ho-Fung Chan; Madhwesha Rao; Graham Norquay; Jim M Wild
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2020-12-09       Impact factor: 9.795

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.